scholarly journals Prognostic role of PIK 3 CA mutations of cell‐free DNA in early‐stage triple negative breast cancer

2015 ◽  
Vol 106 (11) ◽  
pp. 1582-1589 ◽  
Author(s):  
Takashi Takeshita ◽  
Yutaka Yamamoto ◽  
Mutsuko Yamamoto‐Ibusuki ◽  
Toko Inao ◽  
Aiko Sueta ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Early Stage ◽  
Prognostic Role ◽  
Cell Free Dna ◽  
Free Dna

scholarly journals Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study

Cancers ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 995 ◽  
Author(s):  
Shristi Bhattarai ◽  
Sergey Klimov ◽  
Karuna Mittal ◽  
Uma Krishnamurti ◽  
Xiaoxian Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Androgen Receptor ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Molecular Subtype ◽  
Good Prognosis ◽  
Prognostic Role ◽  
Primary Tumors ◽  
Total N

Background: The androgen receptor (AR) has emerged as a potential therapeutic target for AR-positive triple-negative breast cancer (TNBC). However, conflicting reports regarding AR’s prognostic role in TNBC are putting its usefulness in question. Some studies conclude that AR positivity indicates a good prognosis in TNBC, whereas others suggest the opposite, and some show that AR status has no significant bearing on the patients’ prognosis. Methods: We evaluated the prognostic value of AR in resected primary tumors from TNBC patients from six international cohorts {US (n = 420), UK (n = 239), Norway (n = 104), Ireland (n = 222), Nigeria (n = 180), and India (n = 242); total n = 1407}. All TNBC samples were stained with the same anti-AR antibody using the same immunohistochemistry protocol, and samples with ≥1% of AR-positive nuclei were deemed AR-positive TNBCs. Results: AR status shows population-specific patterns of association with patients’ overall survival after controlling for age, grade, population, and chemotherapy. We found AR-positive status to be a marker of good prognosis in US and Nigerian cohorts, a marker of poor prognosis in Norway, Ireland and Indian cohorts, and neutral in UK cohort. Conclusion: AR status, on its own, is not a reliable prognostic marker. More research to investigate molecular subtype composition among the different cohorts is warranted.

scholarly journals Prevalence and Prognostic Role of Triple-Negative Breast Cancer by Race: A Surveillance Study

2011 ◽  
Vol 11 (5) ◽  
pp. 332-341 ◽  
Author(s):  
Helen Swede ◽  
David I. Gregorio ◽  
Susan H. Tannenbaum ◽  
Jessica A. Brockmeyer ◽  
Christine Ambrosone ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Surveillance Study ◽  
Prognostic Role

scholarly journals Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer

2019 ◽  
Vol 30 ◽  
pp. iii19
Author(s):  
R. Bajaj ◽  
D. Doval ◽  
R. Tripathi ◽  
T. Sridhar ◽  
A. Korlimarla ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Locally Advanced ◽  
Prognostic Role

scholarly journals Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer

2013 ◽  
Vol 7 (1) ◽  
pp. 278-284 ◽  
Author(s):  
JELENA MAKSIMENKO ◽  
ARVIDS IRMEJS ◽  
MIKI NAKAZAWA-MIKLASEVICA ◽  
INGA MELBARDE-GORKUSA ◽  
GENADIJS TROFIMOVICS ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Brca1 Mutation ◽  
Prognostic Role

scholarly journals Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer

2018 ◽  
Vol Volume 10 ◽  
pp. 4891-4898 ◽  
Author(s):  
Kuojun Ren ◽  
Yachao Yin ◽  
Fang He ◽  
Yi Shao ◽  
Shengying Wang
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Neutrophil To Lymphocyte Ratio ◽  
Prognostic Role ◽  
Lymphocyte Ratio
Sign in / Sign up

Export Citation Format

Share Document